Navigation Links
Apexus Announces HRSA's 340B Prime Vendor Contract Renewal
Date:9/11/2012

IRVING, Texas, Sept. 11, 2012 /PRNewswire/ -- The Health Resources and Services Administration (HRSA) has elected to continue its relationship with Apexus by renewing for another year the agreement making Apexus the government's prime vendor for the 340B program. HRSA chose to exercise this one year renewal following a careful audit and review of Apexus' proven ability to maintain, coordinate and advance the 340B Prime Vendor Program.

The agreement between Apexus and HRSA, effective September 10, 2009, has a term of two years, with three one-year renewal options. HRSA exercises the one-year renewal options each year after reviewing Apexus's abilities and performance against other potential vendors.

"We are pleased to continue our relationship with HRSA," said Christopher Hatwig, Vice President at Apexus. "As the government's prime vendor for the 340B program, we believe the program is an essential federal program, and we are committed to providing value to the eligible organizations we serve. Since our partnership began, in addition to regulatory discounts on covered outpatient drugs, the Program has added numerous value-added products and services."

The 340B Drug Pricing Program is a Federal program that requires drug manufacturers to provide outpatient drugs to eligible safety-net health organizations at a reduced price to ensure patient access to medications, which is a key component of successful clinical pharmacy services and providing a high-quality continuum of care. As the contractor to the 340B Prime Vendor, Apexus is responsible for negotiating pharmaceutical pricing below the 340B price as well as improving access to affordable medications by establishing a distribution network for pharmaceuticals to covered entities.

"We believe the 340B Drug Pricing Program helps improve access to affordable medications for covered entities and underserved patient groups," adds Hatwig. "Without the Program, we believe many of the nation's uninsured and under insured would not have adequate access to affordable medications. This Program helps alleviate additional financial burdens on the nation's safety net providers and American tax payers."

About Apexus
Founded in 2007, Apexus Inc., a nonprofit corporation, is the HRSA's Office of Pharmacy Affairs awarded contractor to serve as the prime vendor for the 340B Program. Based in Irving, Texas, the prime vendor's role is to secure sub-ceiling discounts on outpatient drug purchases and discounts on other pharmacy related products and services for participating public hospitals, community health centers, and other safety-net health care providers electing to join the program. For more information on Apexus, visit www.340Bpvp.com.


'/>"/>
SOURCE Apexus
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NuAire Announces New In-VitroCell Energy Saver CO2 Incubators
2. Thoratec Announces Presentations At Upcoming Investor Conferences
3. Hemp, Inc. Division Marijuana Inc. Announces Medical Grow Tour Venue In Portland, Oregon
4. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
5. Neurotech Reports Announces New Conference Dedicated to Consumer Applications of Neurotechnology
6. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
7. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
8. CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
11. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a ... (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the 90 ... their favorite way to cook a hot dog, far outpacing other cooking methods such ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):